New drug duo aims to tame aggressive blood cancer

NCT ID NCT05768711

Summary

This study is testing whether combining two existing cancer drugs, azacitidine and venetoclax, can effectively treat adults with higher-risk chronic myelomonocytic leukemia (CMML), a serious blood and bone marrow disorder. The main goals are to see if the combination is safe and if it can reduce the cancer burden and prevent it from worsening or turning into acute leukemia. The trial is for patients who have not received certain prior treatments for their CMML.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHRU de Limoges

    Limoges, 87046, France

  • CHU Hôtel Dieu

    Nantes, 44093, France

  • CHU d'Amiens

    Amiens, 80054, France

  • CHU d'Angers

    Angers, 49033, France

  • CHU de Bordeaux - Hôpital Haut-Lévêque

    Pessac, 33604, France

  • CHU de Grenoble

    Grenoble, 38043, France

  • CHU de Montpellier - Hôpital Saint Eloi

    Montpellier, 34295, France

  • CHU de Poitiers

    Poitiers, 86021, France

  • CHU de Tours - Hôpital Bretonneau

    Tours, 37000, France

  • Centre Henri Becquerel

    Rouen, 76038, France

  • Centre Hospitalier Annecy Genevois - Site d'Annecy

    Pringy, 74374, France

  • Centre Hospitalier de Mont de Marsan

    Mont-de-Marsan, 40000, France

  • Centre hospitalier Lyon sud

    Pierre-Bénite, 69495, France

  • Hôpital Archet 1

    Nice, 06200, France

  • Hôpital Avicenne

    Bobigny, 93009, France

  • Hôpital Claude Huriez

    Lille, 59037, France

  • Hôpital Cochin

    Paris, 75014, France

  • Hôpital NOVO

    Pontoise, 95300, France

  • Hôpital Pontchaillou

    Rennes, 35033, France

  • Hôpital Saint Louis

    Paris, 75010, France

  • Hôpital privé Sévigné

    Cesson-Sévigné, 35510, France

  • Hôpital privé du Confluent SAS

    Nantes, 44277, France

  • IUCT oncopole

    Toulouse, 31059, France

  • Institut Gustave Roussy

    Villejuif, 94800, France

Conditions

Explore the condition pages connected to this study.